| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |